XML 51 R14.htm IDEA: XBRL DOCUMENT v3.20.1
STOCKHOLDERS' EQUITY AND DILUTIVE EQUITY INSTRUMENTS
3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
STOCKHOLDERS' EQUITY AND DILUTIVE EQUITY INSTRUMENTS

(5)

STOCKHOLDERS' EQUITY AND DILUTIVE EQUITY INSTRUMENTS

Accumulated Other Comprehensive Income (Loss) (OCI)

 

The changes in accumulated other comprehensive income (loss) by component, net of tax, for the quarters ended March 31, 2020 and 2019 are as follows:

 

 

 

Three months ended March 31, 2020

 

 

Three months ended March 31, 2019

 

 

 

Balance

 

 

Gains/(losses)

 

 

 

 

Remaining

 

 

Balance

 

 

Gains/(losses)

 

 

 

Remaining

 

 

 

at

 

 

recognized

 

 

 

 

balance

 

 

at

 

 

recognized

 

 

 

balance

 

(In thousands)

 

12/31/19

 

 

in OCI

 

 

 

 

3/31/20

 

 

12/31/18

 

 

in OCI

 

 

 

3/31/19

 

Pension benefits

 

$

(236

)

 

 

369

 

 

 

 

 

133

 

 

$

2,194

 

 

 

 

 

 

 

2,194

 

 

Dilutive Equity Instruments

 

We had 2,133,439 and 4,327,358 incremental "in-the-money" warrants and restricted stock units at March 31, 2020 and 2019, respectively, which are as follows:

 

 

 

Total shares outstanding including warrants and restricted stock units

 

March 31, 2020

 

 

March 31, 2019

 

Common shares outstanding

 

 

40,259,917

 

 

 

37,381,954

 

New creditor warrants (strike price $0.001 per common share)

 

 

821,308

 

 

 

2,070,243

 

GulfMark creditor warrants (strike price $0.01 per common share)

 

 

952,154

 

 

 

2,047,015

 

Restricted stock units

 

 

359,977

 

 

 

210,100

 

Total

 

 

42,393,356

 

 

 

41,709,312

 

 

We also had 5,923,399 shares of “out-of-the-money” warrants outstanding at March 31, 2020 and 2019, respectively. Included in these “out-of-the-money” warrants are Series A Warrants, Series B Warrants and GLF Equity Warrants which have exercise prices of $57.06, $62.28, and $100.00, respectively.